Telomerase Activating Compounds for Enhanced Plant Fertility and Resistance

Publication ID: 24-11857516_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Telomerase Activating Compounds for Enhanced Plant Fertility and Resistance,” Published Technical Disclosure No. 24-11857516_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857516_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,516.

Summary of the Inventive Concept

The inventive concept applies telomerase activating compounds to improve crop yields by enhancing plant fertility and resistance to environmental stressors, promoting healthy aging in companion animals, treating telomere-related disorders in aquatic species, monitoring telomerase activity in industrial microorganisms, and enhancing the shelf life of perishable food products.

Background and Problem Solved

The original patent disclosed telomerase activating compounds for use in fertility and related applications. However, the limitations of this patent are that it only focuses on human fertility and does not explore the potential of these compounds in other industries. The new inventive concept addresses this limitation by applying the core technology to entirely different fields, solving the problem of limited crop yields, unhealthy aging in companion animals, and reduced shelf life of perishable food products.

Detailed Description of the Inventive Concept

The new inventive concept involves the use of telomerase activating compounds in various industries, including agriculture, veterinary medicine, aquaculture, industrial microbiology, and food preservation. In agriculture, these compounds can be applied to plants to enhance their fertility and resistance to environmental stressors, resulting in improved crop yields. In veterinary medicine, telomerase activating compounds can be administered to companion animals to promote healthy aging and improve their overall healthspan. In aquaculture, these compounds can be used to treat telomere-related disorders in aquatic species. In industrial microbiology, a device can be developed to monitor telomerase activity in microorganisms, optimizing fermentation conditions. Finally, in food preservation, telomerase activating compounds can be applied to extend the telomere length of microorganisms used in food preservation, enhancing the shelf life of perishable food products.

Novelty and Inventive Step

The new inventive concept is novel and non-obvious as it applies the core technology of telomerase activating compounds to entirely new industries, solving previously unaddressed problems. The inventive step lies in the recognition of the potential of these compounds in fields beyond human fertility and the development of new applications and use cases.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of telomerase activating compounds, varying dosages and administration routes, and combining these compounds with other agents to enhance their effects. Variations could also include the development of new devices or systems for monitoring telomerase activity or applying these compounds in different industries.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, veterinary medicine, aquaculture, industrial microbiology, and food preservation. The target market includes companies and organizations operating in these industries, as well as research institutions and government agencies interested in improving crop yields, promoting healthy aging in companion animals, and enhancing the shelf life of perishable food products.

CPC Classifications

SectionClassGroup
A A61 A61K31/09
A A61 A61K31/137
A A61 A61K31/4025
A A61 A61K31/4545
A A61 A61K31/5377
A A61 A61K31/66
A A61 A61P15/08

Original Patent Information

Patent NumberUS 11,857,516
TitleTelomerase activating compounds for use in fertility and related applications
Assignee(s)Neuromagen Pharma, Ltd.